RUNX2-modifying enzymes: therapeutic targets for bone diseases
نویسندگان
چکیده
منابع مشابه
Proteolytic Enzymes as Therapeutic Targets
treat acquired immunodeficiency syndrome [AIDS]) and against the angiotensin-converting enzyme (ACE) (to treat hypertension) are the only protease inhibitors approved by the FDA for therapeutic use (see Table 1). HIV-1 protease is an aspartic protease that is necessary for the processing of viral polypeptides late in the viral replicative cycle. Inhibition of this activity prevents formation of...
متن کاملIntegrins as Therapeutic Targets for Respiratory Diseases
Integrins are a large family of transmembrane heterodimeric proteins that constitute the main receptors for extracellular matrix components. Integrins were initially thought to be primarily involved in the maintenance of cell adhesion and tissue integrity. However, it is now appreciated that integrins play important roles in many other biological processes such as cell survival, proliferation, ...
متن کاملBrain Cytochrome p450 enzymes: a possible Therapeutic Targets for Neurological Diseases
Neurological diseases (ND) afflict hundreds of millions of people worldwide and constitute 12% of total deaths of the population all around the world. According to a global study conducted by the World Health Organization, 8 out of 10 disorders in the 3 highest disability classes are neurologic problems. Commonly they have disabling consequences, compromising severely the quality of the life of...
متن کاملNew therapeutic targets for cancer bone metastasis.
Bone metastases are dejected consequences of many types of tumors including breast, prostate, lung, kidney, and thyroid cancers. This complicated process begins with the successful tumor cell epithelial-mesenchymal transition, escape from the original site, and penetration into the circulation. The homing of tumor cells to the bone depends on both tumor-intrinsic traits and various molecules su...
متن کاملHuman isoprenoid synthase enzymes as therapeutic targets
In the human body, the complex biochemical network known as the mevalonate pathway is responsible for the biosynthesis of all isoprenoids, which consists of a vast array of metabolites that are vital for proper cellular functions. Two key isoprenoids, farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP) are responsible for the post-translational prenylation of small GTP-binding ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Experimental & Molecular Medicine
سال: 2020
ISSN: 1226-3613,2092-6413
DOI: 10.1038/s12276-020-0471-4